Herpes Simplex Virus Treatment Market To Reach $4.08 Billion By 2030

 

The global Herpes Simplex Virus Treatment Market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth. 

List of Key Players in Herpes Simplex Virus (HSV) Treatment Market

• GSK plc
• Emcure Pharmaceuticals Ltd.
• Carlsbad Tech
• Glenmark Pharmaceuticals Inc.
• Viatris, Inc.
• Fresenius Kabi AG
• Teva Pharmaceuticals Industries Ltd.
• Apotex Inc.
• Sanofi
• Novartis AG

Related Press Release@ Herpes Simplex Virus Treatment Market Report

Herpes Simplex Virus Treatment Market Report Highlights

• By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
• By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
• By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
• North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure

Herpes Simplex Virus Treatment Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 2.56 billion
Revenue forecast in 2030	USD 4.08 billion
Growth rate	CAGR of 8.1% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

 

Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/453481/rfc

Herpes Simplex Virus Treatment Market Segmentation

Grand View Research has segmented the global herpes simplex virus treatment market based on type, drug, vaccine, route of administration, end-use, and region:

Herpes Simplex Virus Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Herpes Simplex Virus-1 (HSV-1)
• Herpes simplex virus-2 (HSV-2)

Herpes Simplex Virus Treatment Drug Outlook (Revenue, USD Million, 2018 - 2030)

• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs

Herpes Simplex Virus Treatment Vaccine Outlook (Revenue, USD Million, 2018 - 2030)

• Simplirix
• Others

Herpes Simplex Virus Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Injectable
• Topical

Herpes Simplex Virus Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Herpes Simplex Virus Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Norway
• Sweden
• Denmark
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Powered Wheelchair Market – Industry Insights By Application And Product

 

The global Powered Wheelchair Market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the increasing disability rates, a growing aging population, technological advancements, and government initiatives and regulations. According to the Centers for Disease Control and Prevention (CDC), around 27%, 1 in every 4 adults in the United States have some type of disability out of which 12.1% of adults in the United States struggle significantly to walk or climb stairs due to mobility impairment. In the United States, there are an estimated 3.3 million wheelchair users, and this figure is rising annually. Due to the rise in the baby boomer group who has a high need for wheelchairs, the demand for wheelchairs is rising.

Moreover, the rising customization offered by several players is anticipated to boost the market. Wheelchairs are being designed with a greater focus on customization to meet individual needs and preferences. Manufacturers are offering options for adjustable seating, backrests, armrests, and other features, allowing users to have a personalized and comfortable experience.

The COVID-19 outbreak negatively impacted the market in the initial phase of 2020. Due to lockdowns and travel and manufacturing restrictions, the pandemic caused disruptions in the world's supply-chain networks. This has affected the production and distribution of wheelchairs and their components, leading to potential delays in manufacturing and delivery. However, the market recovered soon as there was demand was a surge in demand for healthcare equipment, including wheelchairs, in medical facilities. Hospitals and clinics required additional equipment to manage patients with mobility issues, which contributed to an increased demand for both manual and powered wheelchairs.

List of Key Players in Powered Wheelchair Market

• Drive Medical Design & Manufacturing
• Invacare
• Sunrise Medical LLC
• Karman Healthcare
• Quantum Rehab
• Numotion
• Pride Mobility Products Corp.
• Ostrich Mobility
• MEYRA
• Jinmed

Related Press Release @ Powered Wheelchair Market Report

Powered Wheelchair Market Report Highlights

• The marketing the healthcare industry was estimated at USD 2.01 billion in 2023 and is expected to reach USD 3.21 billion in 2030
• The market for powered wheelchairs is expected to expand at a compound annual growth rate of 6.9% from 2024 to 2030 to reach USD 3.21 billion by 2030
• North America dominated the global market in 2023 and accounted for the largest revenue share of 47.8%. This growth is owing to the high target population and increased adoption of advanced wheelchairs
• By category, the adult segment dominated the electric wheelchair industry in terms of revenue share of 86.3% in 2023. Adults comprise individuals from the age group of 18 onwards. Disability in older people due to arthritis pain, or stiffness in a knee, hip, ankle, or foot increases the demand for wheelchairs

Powered Wheelchair Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 2.15 billion
Revenue forecast in 2030	USD 3.21 billion
Growth rate	CAGR of 6.9% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

 

Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/452588/rfc

Powered Wheelchair Market Segmentation

Grand View Research has segmented the global powered wheelchair market based on age category, product, portability, end-use, and region:

Powered Wheelchair Age Category Outlook (Revenue, USD Million, 2018 - 2030)

• Adult
• Pediatric

Powered Wheelchair Product Outlook (Revenue, USD Million, 2018 - 2030)

• Front-wheel Drive
• Mid-wheel Drive
• Rear-wheel Drive
• Others

Powered Wheelchair Portability Outlook (Revenue, USD Million, 2018 - 2030)

• Standalone
• Portable

Powered Wheelchair End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Homecare
• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers

Powered Wheelchair Regional Outlook (Revenue in USD Billion 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

gRNA Market Size is Predicted to Witness 18.6% CAGR till 2030

 

The global gRNA Market size is anticipated to reach USD 1.62 billion by 2030 and it is projected to grow at a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of Next-Generation Sequencing (NGS) is significantly boosting the market. As NGS technologies become more prevalent, they empower researchers and scientists with advanced capabilities for genomic analysis and manipulation. NGS enables high-throughput sequencing of genetic material, allowing for the rapid and cost-effective examination of entire genomes. This efficiency is crucial for gRNA applications, as it facilitates the identification and validation of target genes for genetic manipulation. NGS technologies provide a precise and comprehensive understanding of genomic sequences. This precision is vital for designing gRNAs with high specificity, ensuring accurate targeting of genes during the gene editing process using CRISPR/Cas systems.

Furthermore, the increasing investments by biotechnology and pharmaceutical companies for R&D activities are expected to fuel the market in the coming years. The development of user-friendly and affordable gRNA synthesis kits and services has made CRISPR-Cas9 technology more accessible to researchers of all levels. The continuous discovery of novel applications for CRISPR-Cas9 fuels the demand for gRNA.

Additionally, the launch of new gRNA final products can drive innovation, expand the market reach of players, and accelerate the adoption of gene editing technologies, contributing to the overall growth & advancement of the market. For instance, in October 2023, Synthego, a prominent provider of genome engineering solutions, launched IND-enabling (INDe) gRNAs. This transformative offering marks a significant advancement in the CRISPR-based cell and gene therapy preclinical pipeline. By providing researchers with high-quality gRNAs meticulously designed for GLP-regulated preclinical and IND-enabling studies, this product incorporates comprehensive IND-compliant materials and documentation throughout its design and production. Thus, it will drive the market growth.

Related Press Release@ gRNA Market Report

gRNA Market Report Highlights

• On the basis of product & services, the product segment accounted for the largest revenue share of 73.4% in 2023. These products offer high accuracy, efficiency, and specificity in gene editing, making them popular among researchers is one of the primary drivers driving market expansion
• On the basis of gRNA type, the research-use segment dominated the market share in 2023. A large number of research programs conducted across various research institutes demand research-grade gRNA is driving up demand for this segment
• On the basis of application, the genome engineering segment dominated the market share in 2023. This growth can be attributed to the increasing demand for advanced genetic tools for research and therapeutic purposes
• On the basis of end-use, the pharmaceutical & biotechnology companies segment dominated the market share in 2023. The adoption of gRNA in precision medicine by pharmaceutical and biotech companies fuels its market growth as it becomes integral to the development of personalized therapies
• North America dominated the global industry in 2023 with a revenue share of 52.6% owing to the presence of key market players in the region. The majority of the key companies in this region have been actively involved in R&D activities involving gRNA

gRNA Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 581.3 million
Revenue forecast in 2030	USD 1.62 billion
Growth rate	CAGR of 18.6% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

 

Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/456351/rfc

gRNA Market Segmentation

Grand View Research has segmented the global gRNA market based on product & services, gRNA type, application, end-use, and region.

gRNA Product & Services Outlook (Revenue, USD Million, 2018 - 2030)

• Products
• gRNA Final Products
• gRNA Synthesis Products

• gRNA Synthesis Kits
• Plasmids
• Others
• Custom gRNA Synthesis Services

gRNA Type Outlook (Revenue, USD Million, 2018 - 2030)

• Research-Use
• GMP-grade

gRNA Application Outlook (Revenue, USD Million, 2018 - 2030)

• Genome Engineering
• Disease Model Studies
• Functional Genomics
• Epigenetics
• Others

gRNA End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• CMOs & CROs

gRNA Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com